X

Trial Profile

An Observational, Multicenter, Open-label Study of YONDELIS + PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Trabectedin (Primary) ; Doxorubicin liposomal
Indications Ovarian cancer
Focus Adverse reactions
Acronyms NIS-OvaYond
Sponsors PharmaMar

Most Recent Events

01 Jun 2018 Results published in the Journal of Cancer Research and Clinical Oncology
12 Sep 2017 Results (n=77; as of Dec 2016) presented at the 42nd European Society for Medical Oncology Congress
13 Apr 2017 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com